2010-02-10 03:59:34 - Recently published research from Datamonitor, "Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan", is now available at Fast Market Research

Over the past decade, vaccines have resurfaced as an attractive commercial proposition for Pharma. The developed world has been the initial focus of vaccine makers due to the better healthcare infrastructure and higher price levels. However, facing increasingly saturated markets in the West, companies are looking to expand into new geographies, such as Asia's emerging markets.

Scope

* Strategic analysis of key domestic vaccine companies as well as the position of major international players
* Thorough assessment of the market environment for vaccines in India, China, Taiwan and Korea
* Review of existing vaccine recommendations, coverage rates and promising future indications
* In-depth discussion of strengths, weaknesses, opportunities and threats for each market from a vaccine maker's perspective

Highlights

Immunizations in

India are currently restricted to a limited public vaccination schedule, with the insufficient healthcare infrastructure in rural areas contributing to low coverage rates. Commercial opportunities lie in providing premium vaccines to the emerging private sector and in partnering with domestic players.

China is a very challenging market for international vaccine companies. The country remains difficult to penetrate due to the high language and cultural barriers, opaque regulatory environment and strong government influence. Local expertise and connections are crucial, making partnerships with domestic players a key strategy for market access.

With only one domestic vaccine player, Taiwan relies on imports. Looking to decrease the country's reliance on imports and to establish it as a hub for biotechnology, the Taiwanese government is encouraging international vaccine makers to build manufacturing and R&D facilities in the country, offering tax rebates and advance purchase agreements.

Reasons to Purchase

* Review portfolios and deals for key domestic vaccine companies as well as the position of major international vaccine makers
* Gain insight into the market environment for vaccines through a review of demographic, economic and regulatory trends
* Understand challenges, unmet needs and future opportunities by learning about the views of key opinion leaders from each country

For more information or to purchase this report, go to:
- www.fastmr.com/prod/43007_stakeholder_opinions_vaccines_in_emerg ..

Partial Table of Contents:

ABOUT DATAMONITOR HEALTHCARE 2
About the Infectious diseases pharmaceutical analysis team 2
EXECUTIVE SUMMARY 3
Strategic scoping and focus 3
Datamonitor insight into vaccines in emerging markets (Asia) 3
Limitations 5
Related reports 6
Upcoming related reports 7
CHAPTER 1 OVERVIEW OF THE FOUR MAIN ASIAN EMERGING MARKETS FOR VACCINES 9
China and India offer a large, untapped demographic opportunity for vaccine makers 9
The increasing wealth in Asia has led to the emergence of a promising private sector market for vaccines 10
There is a promising opportunity for vaccines against endemic diseases in Asia 12
Vaccination coverage and recommendations vary across the key emerging Asian markets 14
There are significant differences regarding the general environment for vaccines in India, China, Taiwan and South Korea 17
CHAPTER 2 INDIA 20
Summary 20
General characteristics 21
Demographics 22
Economics 24
Healthcare expenditure and access 24
The Indian vaccines market 27
Historic development 27
Current market situation 28
Key stakeholders in India's vaccination system 32
Existing recommendations, coverage, available vaccines 33
Vaccination recommendations 33
Vaccination coverage 38
Available vaccines 39
Regulatory process for vaccines 42
Key vaccine players in India 45
General overview 45
Multinational corporations 48
GlaxoSmithKline 50
Sanofi Pasteur 50
Novartis 51
Wyeth, Merck & Co 52
Local vaccine players 53
Serum Institute of India 58
Biological E 60
Panacea Biotec 62
Shantha Biotechnics 66
Bharat Biotech 68
Bio-Med 70
Indian Immunologicals 71
Key future target indications 73
SWOT analysis of India as a target market for vaccine producers 77
Best strategy for market penetration 84
CHAPTER 3 CHINA 85
Summary 85
General characteristics 86
Demographics 86
Economics 89
Healthcare spend and access 89
The Chinese vaccines market 92
Historic development 92
Current market situation 92
Key stakeholders in China's vaccination system 94
Existing recommendations, coverage, available vaccines 95
Vaccination recommendations 95
Vaccination coverage 97
Available vaccines 99
Regulatory process for vaccines 101
Key vaccine players in China 104
General overview 104
Multinational corporations 106
GlaxoSmithKline 107
Sanofi Pasteur 108
Novartis, Wyeth, Merck & Co 109
Local vaccine players 109
China National Biotec Group (CNBG) 111
Sinovac 115
Key future target indications 118
SWOT analysis of China as a target market for vaccine producers 120
Best strategy for market penetration 123
CHAPTER 4 TAIWAN 125
Summary 125
General characteristics 126
Demographics 127
Economics 129
Healthcare

Full ToC is available at:
-- www.fastmr.com/catalog/product.aspx?productid=43007&dt=t

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.